RMD Open, published by the BMJ Publishing Group, is a leading open-access journal that has made significant contributions to the fields of Immunology, Immunology and Allergy, and Rheumatology since its inception in 2015. With an impressive Q1 ranking in these categories for 2023, the journal has established itself as an essential platform for the dissemination of high-quality research, case studies, and reviews that advance understanding and treatment strategies in these critical areas of health. As an open-access publication, RMD Open ensures that its content is freely accessible to a global audience, promoting collaboration and knowledge sharing among researchers, clinicians, and students. Based in the United Kingdom at the British Medical Association House, RMD Open is not only dedicated to improving patient care but also to fostering innovative research and discussions in the rapidly evolving landscape of rheumatic diseases.

Orthopedic Research and Reviews is a leading open-access journal dedicated to advancing the field of orthopedics and sports medicine, published by DOVE MEDICAL PRESS LTD since 2009. Situated in New Zealand, this journal has established itself as an essential resource for researchers, practitioners, and students alike, facilitating the dissemination of high-quality research and reviews in orthopedics. With a commendable impact factor reflected in its 2023 ranking in the Q2 quartile of orthopedics, the journal ranks #155 out of 321 in its category on Scopus, placing it in the 51st percentile among peers. The journal aims to publish cutting-edge findings and comprehensive reviews that contribute to the understanding and treatment of musculoskeletal disorders. As an open-access publication, it ensures that vital research is accessible to a global audience, underscoring its commitment to innovation and education in the orthopedic community. Researchers and professionals are encouraged to submit their work, as the journal continues to expand its influence and relevance in the evolving landscape of orthopedic medicine.

European Journal of Rheumatology is a premier, peer-reviewed journal that has been paving the way for innovative research and in-depth analysis in the field of rheumatology since its launch. Published by AVES, this Open Access journal has been accessible to researchers, professionals, and students worldwide since 2014, promoting the sharing of valuable knowledge on rheumatic diseases and their treatment. With an ISSN of 2147-9720 and an E-ISSN of 2148-4279, it provides a prominent platform for groundbreaking studies and clinical evaluations that bridge scientific discovery with practical application. The journal’s mission is to enhance the understanding of rheumatological conditions and facilitate advancements in therapeutic strategies, making it an essential resource for anyone devoted to the improvement of patient care in this dynamic field. The European Journal of Rheumatology is committed to upholding the highest standards of scholarly publishing and aims to foster collaboration among researchers and practitioners across Europe and beyond.

LUPUS is a premier peer-reviewed journal published by SAGE Publications Ltd, focusing on the field of rheumatology, with a specific emphasis on the complexities of lupus and related autoimmune disorders. Since its inception in 1991, the journal has consistently ranked in the Q2 category within the rheumatology field, currently positioned as #29 out of 73 in Scopus, reflecting its significant contributions to research and clinical practice. The journal aims to foster a deeper understanding of lupus through the publication of original research articles, reviews, and clinical studies, making it an essential resource for researchers, clinicians, and students dedicated to advancing knowledge in this vital area of medicine. With an impact factor that underscores its influence, LUPUS serves as a critical platform for sharing innovative findings and engaging discussions within the global scientific community. Although the journal follows a traditional access model, it is situated in the United Kingdom, at 1 Olivers Yard, 55 City Road, London EC1Y 1SP, England, and remains dedicated to supporting the continuous advancement of research in autoimmune diseases.

Osteoarthritis and Cartilage, published by ELSEVIER SCI LTD, stands as a leading journal in the fields of Biomedical Engineering, Orthopedics and Sports Medicine, and Rheumatology. With an impressive impact factor reflective of its significant contribution to these domains, the journal has established a prominent place within the academic community since its inception in 1993. As evidenced by its Q1 quartile rankings across multiple categories, the journal is recognized for its high-quality peer-reviewed research that pushes the boundaries of knowledge regarding osteoarthritis and related cartilage disorders. Its rankings in Scopus, placing it among the top 2% of journals in Orthopedics and Sports Medicine and the top 7% in Rheumatology, further underscore its pivotal role in advancing clinical and biomechanical understandings of joint health. While open access options are not currently available, the journal encourages submissions that explore innovative solutions and therapeutic approaches to musculoskeletal conditions, fostering a collaborative environment among researchers, professionals, and students alike. Situated in the heart of London, it serves as a critical repository for cutting-edge research shaping the future of patient care and bone health.

Current Opinion in Rheumatology, published by Lippincott Williams & Wilkins, stands as a vital resource in the field of rheumatology. Since its inception in 1989, this prestigious journal has been at the forefront of disseminating cutting-edge research, with a notable Q1 ranking in the 2023 Rheumatology category and an impressive Scopus rank of 7 out of 73, placing it in the 91st percentile. The journal's commitment to presenting insightful reviews and critical analyses of recent advancements and treatment strategies makes it an essential read for professionals, researchers, and students dedicated to the study of rheumatic diseases. Although not an open-access journal, Current Opinion in Rheumatology continues to foster an informed dialogue within the academic community through its high-impact content, ensuring that the latest developments and practices are accessible to those at the vanguard of rheumatology research.

JOURNAL OF RHEUMATOLOGY, published by the J Rheumatol Publ Co, stands as a distinguished platform within the fields of rheumatology and immunology since its inception in 1974. With an impressive impact evidenced by its 2023 rankings—Q1 in Rheumatology and Q2 in both Immunology and Allergy—the journal has secured its position as a vital resource for researchers and practitioners alike. The journal is dedicated to advancing clinical and experimental knowledge in the pathogenesis, diagnosis, and management of rheumatic diseases, providing a rich repository of peer-reviewed articles that drive innovation in treatment protocols and patient care. Although it operates under a subscription model, the journal remains accessible to a broad audience committed to advancing their understanding of these critical areas. Located in Toronto, Canada, it continues to attract contributions from leading experts globally, making it an essential read for anyone keen on staying at the forefront of rheumatological research and practice.

Musculoskeletal Care is a prestigious journal published by WILEY, focusing on the multidisciplinary field of musculoskeletal health. With its ISSN 1478-2189 and E-ISSN 1557-0681, the journal has established itself as a vital resource for researchers, healthcare professionals, and students dedicated to the study and treatment of musculoskeletal disorders. Since its inception in 2003, it has maintained a strong reputation, achieving a Q1 ranking in Chiropractics and notable placements in other relevant categories, including Nursing and Orthopedics. The journal emphasizes the importance of evidence-based practices, innovative therapies, and collaborative research, making it essential reading for those involved in rehabilitation, sports medicine, and rheumatology. Although not an open-access journal, it remains widely accessible through academic institutions and professional organizations, contributing significantly to the ongoing discourse in musculoskeletal care and enhancing the quality of care provided to patients worldwide.

Rheumatology International, published by Springer Heidelberg, is a prestigious journal that focuses on innovative research in the field of rheumatology and immunology. Established in 1981, this peer-reviewed journal has contributed significantly to advancing our understanding of autoimmune disorders, clinical approaches, and therapeutic interventions. It holds a commendable Q2 ranking in the categories of Immunology, Immunology and Allergy, and Rheumatology as of 2023, showcasing its influence and importance within these disciplines. With a robust Scopus ranking—positioned 14 out of 73 in Medicine Rheumatology—it caters to a diverse audience of researchers, clinicians, and students committed to improving patient care and treatment modalities. Although it does not currently offer open access options, the journal remains a vital resource for insights on contemporary challenges and breakthroughs in rheumatological research, published from its base in Heidelberg, Germany.

Reumatologia is a dedicated open-access journal published by TERMEDIA PUBLISHING HOUSE LTD that has been serving the global scientific community since 2005. The journal focuses on the fields of Rheumatology, Immunology, and Allergy, providing a rich platform for researchers and practitioners to share innovative findings, clinical insights, and methodologies. With its roots tracing back to the early 1960s and a steady convergence of quality content through 2024, Reumatologia has secured a place in the academic landscape, currently holding a Q4 rating in Immunology and a Q3 rating in both Immunology and Allergy and Rheumatology categories for 2023. While the journal ranks #42 out of 73 in the Medicine - Rheumatology category, its open-access model ensures that research is widely disseminated, enhancing visibility and accessibility to vital knowledge that shapes therapeutic practices. Located in Poznan, Poland, Reumatologia remains a pivotal source of credible research, fostering collaboration among academics, healthcare professionals, and students internationally.